- A drug delivery and manufacturer with focus on EFFERVESCENT and ORO-DISPERSIBLE formulations (ODT)
- Separate PHARMACEUTICAL and NUTRITIONAL plants
- Product Development
- Contract Manufacturing
- Clinical Study Supplies
- High quality standard, FDA & EMEA approved facility
Alpex Pharma SA
37 Years of Know-How & continuing to innovate to stay on the leading edge.
A high quality formulation development and manufacturing company.
Activities
Main Activity
Licensing-In
Licensing-Out
Development
Co-development
Trading
Drug Product CMO
Drug development
Drug commercialization
Analytical Services
Pre-formulation
Spray-Drying (Partial)
Other Activities
Therapeutic Areas
Cancer supportive therapy (Partial)
Cardiology
CNS
Endocrinology/Diabetes (Partial)
Gastrointestinal
Gynaecology/Women's Health (Partial)
Mental health
Metabolism
Oncology (Partial)
Orthopedics (Partial)
Pain
Respiratory
Rheumatology
Urology (Partial)
Other therapeutic areas
Markets
CH
EU Top 5
Rest of Europe
USA and Canada
Japan
LATAM
MENA
BRICS
ASEAN
Australia
Other market
Drug Stages
Pre-clinical (Partial)
Clinical Phase I/Phase III
Phase I - Phase III
Registration
Market
Generic Plus (505B2)
Generic
Life cycle management
Drug Product Forms
Oral (solid)
Oral (liquid)
Other drug form (Partial)
Certifications
Swissmedic
FDA
European Medicines Agency
EDQM (Partial)
Korea FDA
GMP
EAEU
AIFA
HACCP
Other Certifications (Partial)
